Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


National Research Council of Canada

Latest From National Research Council of Canada

Deals Shaping the Medical Industry (2/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Zelos Therapeutics Inc.

Zelos Therapeutics is developing a next-generation analog of parathyroid hormone for the treatment of osteoporosis and other indications.

Cover Your Graft

Several relatively new companies are making inroads into a new market for bypass assurance with devices that help cardiovascular surgeons intra-operatively assess the patency of each anastomosis. Cardiovascular surgeons historically have been resistant to adjunctive surgical innovations designed to help them do their jobs better. These companies, however, are betting that the difficulty posed by new beating heart coronary artery bypass graft (CABG) procedures will motivate surgeons to slowly but steadily adopt their minimally invasive tools.
Medical Device

Aegera Therapeutics Inc.

Aegera Therapeutics Inc. was formed in May 2000 through the merger of Apoptogen Inc. and Exogen Neurosciences Inc. Aegera will build on the neural signal transduction and apoptosis platforms of its founding companies with a goal of discovering and developing therapeutics for neurodegenerative diseases, peripheral neuropathies and cancer.
See All